31 related articles for article (PubMed ID: 23395558)
1. Why Does Your Uterus Become Malignant? The Impact of the Microbiome on Endometrial Carcinogenesis.
Morańska K; Englert-Golon M; Durda-Masny M; Sajdak S; Grabowska M; Szwed A
Life (Basel); 2023 Nov; 13(12):. PubMed ID: 38137870
[TBL] [Abstract][Full Text] [Related]
2. The ErbB Signaling Network and Its Potential Role in Endometrial Cancer.
Androutsopoulos G; Styliara I; Zarogianni E; Lazurko N; Valasoulis G; Michail G; Adonakis G
Epigenomes; 2023 Oct; 7(4):. PubMed ID: 37873809
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of human papillomavirus-related carcinogenesis in head and neck cancer.
Faraji F; Zaidi M; Fakhry C; Gaykalova DA
Microbes Infect; 2017; 19(9-10):464-475. PubMed ID: 28619685
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Important Gene Ontology Terms and Biological Pathways Related to Pancreatic Cancer.
Yin H; Wang S; Zhang YH; Cai YD; Liu H
Biomed Res Int; 2016; 2016():7861274. PubMed ID: 27957501
[TBL] [Abstract][Full Text] [Related]
5. EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival.
Suo Z; Risberg B; Kalsson MG; Willman K; Tierens A; Skovlund E; Nesland JM
J Pathol; 2002 Jan; 196(1):17-25. PubMed ID: 11748637
[TBL] [Abstract][Full Text] [Related]
6. Expression of the epidermal growth factor system in endometrial cancer.
Adonakis G; Androutsopoulos G; Koumoundourou D; Liava A; Ravazoula P; Kourounis G
Eur J Gynaecol Oncol; 2008; 29(5):450-4. PubMed ID: 19051810
[TBL] [Abstract][Full Text] [Related]
7. Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma.
Abd El-Rehim DM; Pinder SE; Paish CE; Bell JA; Rampaul RS; Blamey RW; Robertson JF; Nicholson RI; Ellis IO
Br J Cancer; 2004 Oct; 91(8):1532-42. PubMed ID: 15480434
[TBL] [Abstract][Full Text] [Related]
8. Tumor-associated macrophages, epidermal growth factor receptor correlated with the triple negative phenotype in endometrial endometrioid adenocarcinoma.
Jiang XF; Tang QL; Shen XM; Li HG; Chen LH; Wang XY; Luo X; Lin ZQ; Jiang GY
Pathol Res Pract; 2012 Dec; 208(12):730-5. PubMed ID: 23122929
[TBL] [Abstract][Full Text] [Related]
9. ErbB2, ErbB3 and ErbB4 expression in urothelial tumors of the upper urinary tract and their prognostic significance.
Galanakis I; Spyropoulos E; Gkialas I; Nomikos A; Souka E; Mitropoulos D
J BUON; 2013; 18(3):653-9. PubMed ID: 24065479
[TBL] [Abstract][Full Text] [Related]
10. Expression and potential role of ErbB receptors in type II endometrial cancer.
Androutsopoulos G; Adonakis G; Liava A; Ravazoula P; Decavalas G
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):204-8. PubMed ID: 23395558
[TBL] [Abstract][Full Text] [Related]
11. [Molecular based targets and endometrial cancer].
Stoyanov S; Ananiev J; Ivanova K; Velev V; Todorova M; Gulubova M
Akush Ginekol (Sofiia); 2015; 54(2):38-45. PubMed ID: 25909140
[TBL] [Abstract][Full Text] [Related]
12. Triple negative endometrial cancer.
Bulsa M; Urasińska E
Ginekol Pol; 2017; 88(4):212-214. PubMed ID: 28509323
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]